Sugi Predict

Sugi Predict / Compounds / SCHEMBL4753036

SCHEMBL4753036

SCHEMBL4753036

CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)CCC(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 2/20 0.56
▸ EPHX1 P07099 3/20 0.52
▸ ALDH1A1 P00352 8/20 0.50
▸ NPSR1 Q6W5P4 3/20 0.49
▸ TSHR P16473 2/20 0.49
▸ MAPT P10636 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ USP2 O75604 1/20 0.49
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ MAPK1 P28482 3/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ MITF O75030 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25559590 1.00 CYP19A1 (0.56) CYP19A1EPHX1ALDH1A1NPSR1TSHR
SCHEMBL3397280 1.00 CYP19A1 (0.56) CYP19A1EPHX1ALDH1A1NPSR1TSHR
SCHEMBL25560369 1.00 CYP19A1 (0.56) CYP19A1EPHX1ALDH1A1NPSR1TSHR
SCHEMBL79842 1.00 CYP19A1 (0.56) CYP19A1EPHX1ALDH1A1NPSR1TSHR
SCHEMBL12449331 1.00 CYP19A1 (0.56) CYP19A1EPHX1ALDH1A1NPSR1TSHR
SCHEMBL29018706 1.00 CYP19A1 (0.56) CYP19A1EPHX1ALDH1A1NPSR1TSHR
SCHEMBL14580755 1.00 CYP19A1 (0.56) CYP19A1EPHX1ALDH1A1NPSR1TSHR
SCHEMBL14565716 1.00 CYP19A1 (0.56) CYP19A1EPHX1ALDH1A1NPSR1TSHR
SCHEMBL8045220 0.99 CYP19A1 (0.55) CYP19A1EPHX1ALDH1A1NPSR1TSHR
SCHEMBL29748715 0.95 CYP19A1 (0.52) CYP19A1EPHX1ALDH1A1NPSR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515215-B1 AGENTS FOR MODULATING THE SENSORY IMPACT OF TOBACCO OR HERBAL SMOKE SENTIENS LLC (US) 2025-06-11 — — EP claimed
CN-120129464-A Flavonoid compound and application thereof 弗门尼舍有限公司 2025-06-10 — — CN claimed
CN-117479843-A Composition for enhancing cooling effect 弗门尼舍公司 2024-01-30 — — CN claimed
CN-117222327-A Methods of using formaldehyde-free antimicrobial compositions in animal byproduct compositions 伊士曼化工公司 2023-12-12 — — CN claimed
CN-116744889-A Composition for enhancing cooling effect 弗门尼舍公司 2023-09-12 — — CN claimed
CN-116568267-A Compositions comprising (bio) -alkanediol and cooling agent 西姆莱斯股份公司 2023-08-08 — — CN claimed
EP-3658109-B1 COOLING AND FLAVOR BOOSTING COMPOSITIONS FIRMENICH & CIE (CH) 2022-12-07 — — EP claimed
US-20220296589-A1 Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using Same ZPNE GROUP GMBH (CH) 2022-09-22 — — US claimed
CN-114513960-A Antimicrobial composition for animal feed 塔明克私人有限公司 2022-05-17 — — CN claimed
WO-2008138162-A1 COMPOSITIONS AND THEIR USE GIVAUDAN SA (CH) 2008-11-20 — — WO claimed
US-20260103459-A1 SUBSTITUTED AZACYLES AS TRPM8 MODULATORS GIVAUDAN SA (CH) 2026-04-16 — — US disclosed
EP-4725476-A2 COMPOSITIONS FOR REDUCING SALTY TASTE AND USES THEREOF Firmenich SA (CH) 2026-04-15 — — EP disclosed
EP-4096714-B1 COMPOSITIONS FOR REDUCING SALTY TASTE AND USES THEREOF FIRMENICH & CIE (CH) 2026-01-28 — — EP disclosed
US-12528801-B2 Substituted azacyles as TRPM8 modulators GIVAUDAN SA (CH) 2026-01-20 — — US disclosed
US-20250387310-A1 COMPOSITIONS THAT ENHANCE THE COOLING EFFECT FIRMENICH INCORPORATED (US) 2025-12-25 — — US disclosed
US-7482378-B2 Physiological cooling compositions MILLENIUM SPECIALTY CHEMICALS, INC. (US) 2009-01-27 — — US disclosed
WO-2008138162-A1 COMPOSITIONS AND THEIR USE GIVAUDAN SA (CH) 2008-11-20 — — WO disclosed
WO-2008138162-A1 COMPOSITIONS AND THEIR USE GIVAUDAN SA (CH) 2008-11-20 — — WO disclosed
US-20080253973-A1 SENSATION MODIFYING TOPICAL COMPOSITION FOAM FOAMIX LTD. (IL) 2008-10-16 — — US disclosed
US-7247743-B1 Process for making monomenthyl esters MILLENNIUM SPECIALTY CHEMICALS, INC. (US) 2007-07-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260103459-A1 SUBSTITUTED AZACYLES AS TRPM8 MODULATORS TRPM8, TRPM7, TRPM5 CYP19A1 2198/4885EPHX1 4381/4885ALDH1A1 1111/4885
US-20080253973-A1 SENSATION MODIFYING TOPICAL COMPOSITION FOAM TRPA1, GPR35, TRPV1 CYP19A1 525/4885EPHX1 1201/4885ALDH1A1 2137/4885
US-12528801-B2 Substituted azacyles as TRPM8 modulators TRPM8, TRPM7, TRPM4 CYP19A1 1861/4885EPHX1 4373/4885ALDH1A1 1465/4885
US-20250387310-A1 COMPOSITIONS THAT ENHANCE THE COOLING EFFECT TAS2R30, TAS2R1, TAS2R20 CYP19A1 3458/4885EPHX1 2205/4885ALDH1A1 540/4885
US-20220296589-A1 Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using Same TAS2R5, TAS2R3, TAS2R16 CYP19A1 4376/4885EPHX1 4326/4885ALDH1A1 653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.